Fingerprint
Dive into the research topics of 'Evidence suggesting that discontinuous dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Evidence suggesting that discontinuous dosing of ALK Kinase Inhibitors May Prolong Control of ALK+ Tumors
Amit Dipak Amin, Soumya S. Rajan, Winnie S. Liang, Praechompoo Pongtornpipat, Matthew J. Groysman, Edgar O. Tapia, Tara L. Peters, Lori Cuyugan, Jonathan Adkins, Lisa M. Rimsza, Yves A. Lussier, Soham D. Puvvada, Jonathan H. Schatz
Research output: Contribution to journal › Article › peer-review
21
Scopus
citations